What did @wegovy.and.me7 actually say?
Honestly? Nothing medically substantive. The transcript is song lyrics, something along the lines of "I'm going home" repeated with phrases about love and hiding. There are no specific claims about Wegovy, semaglutide dosing, weight loss percentages, or side effects anywhere in the spoken content. The medical framing comes entirely from the caption, which reads "BIG HOPES if your starting Wegovy or thinking about it."
So what we're fact-checking here is less a medical claim and more a vibe, a piece of emotional content aimed at people who are either already on semaglutide or considering it. That's worth taking seriously on its own terms, because emotional framing around weight loss drugs shapes how people approach treatment, even when no explicit claims are made.
Does the science back this up?
There's nothing to fact-check in the traditional sense, because no factual claim was made. But the emotional framing of "big hopes" around Wegovy does bump up against real clinical data worth laying out plainly.
Wegovy (semaglutide 2.4 mg, subcutaneous weekly) produced a mean weight loss of approximately 15 percent of body weight in the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine), which is a genuinely significant result. But "big hopes" can become a problem when patients expect dramatic, fast, or permanent results without understanding the full picture. Around 44 percent of participants in STEP 1 experienced nausea, and discontinuation rates due to adverse events hovered near 7 percent. Hope is reasonable. Unrealistic expectations are not.
What did they get wrong (or right)?
They didn't get anything clinically wrong, because they didn't say anything clinical. Credit where it's due: no false dosing claims, no miracle cure language, no pressure to buy a specific product. The caption's community framing, "you're not alone," reflects something that actual behavioral research supports. Social support and shared experience are associated with better adherence in chronic disease management (Thoits, 2011, Journal of Health and Social Behavior).
What's missing, though, matters. Content aimed at people starting Wegovy that leads with "big hopes" without any mention of common side effects, the long-term commitment involved, or the reality that most patients regain weight after stopping (Wilding et al., 2022, Diabetes, Obesity and Metabolism) is incomplete. Not wrong, but incomplete in a way that could set someone up for disappointment.
What should you actually know?
If you're starting Wegovy or thinking about it, here's what the evidence actually says, not what a song lyric implies.
- Semaglutide works by mimicking GLP-1, a hormone that slows gastric emptying and reduces appetite. It's not a willpower substitute and it's not a cure for obesity.
- The STEP trial series showed consistent weight loss results, but those results came with structured lifestyle intervention alongside the medication. The drug alone is not the whole story.
- Weight regain after stopping is well-documented. The STEP 4 withdrawal trial (Rubino et al., 2021, JAMA) showed participants regained about two-thirds of their lost weight within a year of discontinuation.
- GI side effects, particularly nausea and vomiting, are common early on. Gradual dose escalation is the standard approach to managing them.
- "Big hopes" are fine as long as they're grounded. Talk to a licensed clinician before starting, not TikTok.
The bottom line
This video is emotionally supportive content dressed in Wegovy hashtags. The creator made no medical claims, so there's nothing to debunk. But the absence of misinformation isn't the same as the presence of useful information. People searching for Wegovy content deserve more than a song about going home. They deserve accurate context about what the drug does, what it doesn't do, and what happens when you stop taking it. That information exists. It just wasn't in this video.